Victoria’s Secret and Pelotonia Present Scientific Achievement Awards to Women in Cancer Research
Victoria's Secret, in partnership with Pelotonia, awarded $100,000 each to five female cancer researchers during the AACR Annual Meeting. This marks the inaugural presentation of the Global Fund for Women’s Cancers, which will allocate $5 million annually to support research in women's cancers, building on over $21 million previously funded since 2011. The awardees were recognized for their significant contributions to the understanding and treatment of women’s cancers. The Fund aims to enhance collaboration and mentorship among women in cancer research.
- Launch of the Global Fund for Women’s Cancers with $5 million annual funding.
- Recognition of five leading female cancer researchers, boosting their visibility and opportunities.
- Building on over $21 million raised since 2011 for cancer research, reflecting commitment.
- Potential for enhanced collaboration and mentorship among women researchers in cancer.
- None.
Awards are part of new Global Fund for Women’s Cancers to accelerate cancer research
COLUMBUS, Ohio, April 13, 2022 (GLOBE NEWSWIRE) -- Victoria's Secret and impact partner Pelotonia presented five female cancer researchers with scientific achievement awards of
“We have long supported cancer research, but this particular program – accelerating innovation in cancer research for women, by women – is a tangible way we’re bringing to life our brand’s vision of being a leading advocate for women,” said Christy Tostevin, senior vice president of communications and community relations, Victoria’s Secret. “We are exceptionally proud to share The Fund’s inaugural award with five outstanding women who have been leading this critically important work for decades, and are inspiring the next generation of women leaders in cancer.”
According to the International Agency for Research on Cancer, in 2020 alone more than 9.23 million women worldwide were diagnosed with cancer – a number that is expected to rise to 10.3 million women by 2025. Yet research of women’s cancers is historically under-resourced, and there aren’t enough women driving said research. The Fund will accelerate innovation in cancer research for women, by women.
“At Pelotonia, our community has been working tirelessly for more than a decade to fuel scientific breakthroughs; we’re thrilled to partner with Victoria’s Secret in this exciting new initiative that will fund critical research in the field of women’s cancers while also building an essential collaborative platform that will accelerate the achievements of the award recipients and the next generation of researchers,” said Alida Smith, chief marketing officer, Pelotonia. “Much needed financial support, combined with a focused, driven desire between multiple organizations to change the outcome for so many people who will be diagnosed with cancer in the future, will result in massive global impact.”
Recipients of the inaugural scientific achievement awards include:
- Joan S. Brugge, PhD, FAACR Harvard Medical School, Boston, Massachusetts
For lifelong investigations dedicated to unraveling breast cancer initiation, progression and drug resistance that contribute to human carcinogenesis.
- Susan M. Domchek, MD University of Pennsylvania, Philadelphia, Pennsylvania
For demonstrating that genetic testing for high penetrance breast cancer susceptibility genes can improve risk assessment, inform appropriate risk reduction strategies and be used to develop targeted therapeutics.
- Karen H. Lu, MD The University of Texas MD Anderson Cancer Center, Houston, Texas
For fundamental studies of endometrial cancer in Lynch Syndrome, and the prevention of ovarian and sporadic endometrial cancers.
- Lisa A. Newman, MD, MPH New York-Presbyterian/Weill Cornell Medical Center, New York, New York
For significantly advancing the understanding of the etiology of breast cancers in African and African American women.
- Martine J. Piccart, MD, PhD, FAACR Université Libre de Bruxelles, Brussels, Belgium
For visionary and unparalleled leadership in advancing breast cancer clinical trials and drug development.
“We were thrilled to recognize these five remarkable female researchers at this year’s AACR Annual Meeting,” said Margaret Foti, PhD, MD (hc), chief executive officer, AACR. “Drs. Brugge, Domchek, Lu, Newman, and Piccart have made seminal contributions to our progress against breast and gynecologic cancers. Collectively, their research has deepened our understanding of these diseases, improved cancer prevention and screening techniques, led to improvements in medical and surgical treatments and saved countless lives worldwide.”
In addition to the
For more information, please visit pelotonia.org/vsfund.
About Victoria’s Secret
Victoria’s Secret (NYSE: VSCO) is the world’s largest intimates specialty retailer offering a wide assortment of modern, fashion-inspired collections including signature bras, panties, lingerie, casual sleepwear and athleisure, as well as award-winning prestige fragrances and body care. With nearly 1,400 retail stores worldwide and a predominately female workforce of more than 30,000, Victoria’s Secret boasts the largest team of specialty trained bra fit experts worldwide. Victoria’s Secret is committed to inspiring women around the world with products and experiences that uplift and champion them and their journey while creating lifelong relationships and advocating for positive change.
About Pelotonia
Pelotonia exists to engage, inspire, and challenge a community committed to change the world by accelerating innovative cancer research. Since its founding in 2008, Pelotonia has raised over
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 50,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 129 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops—the largest of which is the AACR Annual Meeting, with more than 74,000 attendees for the 2020 virtual meetings and more than 22,500 attendees for past in-person meetings. In addition, the AACR publishes 10 prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.
Contacts | |
Gabby Blauert Pelotonia (708) 629-9618 cell gblauert@pelotonia.org | Brooke Wilson Victoria’s Secret & Co. communications@victoria.com |
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ed293a6c-6eb4-47ab-bc2a-d1991c704350
FAQ
What is the Global Fund for Women’s Cancers launched by Victoria's Secret?
How much funding did each female researcher receive at the AACR Annual Meeting?
What are the main objectives of the Global Fund for Women’s Cancers?
How long has Victoria's Secret been involved in cancer research funding?